Finerenone + empagliflozin
- 1 lab in 1 country
- Funders: Jiangxi Provincial Natural Science Foundation and 2 more
Associations
1Hyperkalaemia
upin humans1RR 2.48
1 study
Hyperkalaemia
upin humans1RR 2.48
Finerenone + empagliflozin raises the risk of hyperkalaemia in humans (RR 2.48, 95% CI: 1.22-5.06).
Reviewcompared with empagliflozin alone
Diabetes, obesity & metabolism17 Sep 2026
Latest
1 in 12 monthsDiabetes, Obesity & Metabolism
Comparative Cardiorenal Efficacy and Safety of Finerenone, SGLT2 Inhibitors, Semaglutide and Their Combination in Diabetic Kidney Disease
Meta-analysis of randomised trialsSGLT2 inhibitors
ADA Scientific Sessions 2025 Abstract
The Confidence Trial—Efficacy/Safety of Combining Finerenone with Empagliflozin in People with Chronic Kidney Disease and Type 2 Diabetes
Trial in peopleInterventions